7 Results

People

  1. Giralt
    Giralt
  2. Gyurkocza
    Gyurkocza
  3. Jakubowski
    Jakubowski
  4. Perales
    Perales
  5. Castro-Malaspina
    Castro-Malaspina
  6. Papadopoulos
    Papadopoulos
  7. Borrill
    Borrill
  8. Devlin
    Devlin
  9. Koehne
    Koehne
  10. Kosuri
    Kosuri

Groups

  1. Bone Marrow Transplant (7)
  2. Center for Hematologic Malignancies (7)
  3. Department of Medicine (7)
  4. Hematologic Malignancies, Division of (7)
  5. Survivorship Research (7)
  6. Biostatistics Service (5)
  7. CTCR Scholars (5)
  8. DigITs Research Group (5)
  9. Epidemiology and Biostatistics (5)
  10. MSK Grad Students (5)
  1. "Hematologic Malignancies, Division of"
  2. "Bone Marrow Transplant"
  3. "Ann Jakubowski"
  4. "Department of Medicine"
  5. "Center for Hematologic Malignancies"
  6. "Taylor Borrill"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (3)
Groups
  1. Bone Marrow Transplant (7)
  2. Center for Hematologic Malignancies (7)
  3. Department of Medicine (7)
  4. Hematologic Malignancies, Division of (7)
  5. Survivorship Research (7)
  6. Biostatistics Service (5)

More Groups

People
  1. Ann Jakubowski (7)
  2. Boglarka Gyurkocza (7)
  3. Miguel-Angel Perales (7)
  4. Sergio Giralt (7)
  5. Taylor Borrill (7)
  6. Esperanza Papadopoulos (6)

More People

Years
  1. 2018 (4)
  2. 2017 (1)
  3. 2016 (1)
  4. 2015 (1)
Publications
  1. Biology of Blood and Marrow Transplantation (6)
  2. Blood (1)
Publishers
  1. Elsevier Inc. (6)
  2. American Society of Hematology (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Disease progression is main barrier to allogeneic hematopoietic stem cell transplantation (HCT) in patients with newly diagnosed and relapsed acute leukemia
    Meeting Abstract

    Preston, E. V.; Chinapen, S.; Borrill, T.; Davis, E.; Shaffer, B. C.; Tamari, R.; Jakubowski, A. A.; Perales, M. A.; Ponce, D. M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Early CMV reactivation adversely impacts blood counts recovery at 1 year post-transplant in recipients of CD34(+) selected graft
    Meeting Abstract

    Tamari, R.; Cho, C.; Hilden, P.; Maloy, M.; Borrill, T.; Politikos, I.; Papanicolaou, G. A.; Jakubowski, A. A.; Gyurkocza, B.; Shaffer, B. C.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Effects of late toxicities on outcomes in long-term survivors of ex-vivo CD34(+)-selected allogeneic hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Impact of toxicity on survival for older adult patients after CD34(+) selected allogeneic hematopoietic stem cell transplantation
    Journal Article

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Cho, C.; Devlin, S. M.; Borrill, T.; Carlow, D. C.; Avecilla, S. T.; Meagher, R. C.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • The impact of toxicities on first-year outcomes after ex vivo CD34(+)-selected allogeneic hematopoietic cell transplantation in adults with hematologic malignancies
    Journal Article

    Kosuri, S.; Herrera, D. A.; Scordo, M.; Shah, G. L.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Nieves, J.; Borrill, T.; Carlow, D. C.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Fractionated infusion of hematopoietic progenitor cells (HPC) does not improve neutrophil recovery or survival in patients undergoing allogeneic
    Meeting Abstract

    Kosuri, S.; Gyurkocza, B.; Devlin, S. M.; Maloy, M.; Ciolino, C.; Borrill, T.; Jakubowski, A. A.; Papadopoulos, E.; Castro-Malaspina, H.; Koehne, G.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Fractionated infusion of hematopoietic progenitor cells does not improve neutrophil recovery or survival in patients undergoing allogeneic hematopoietic cell transplantation for hematologic malignancies
    Meeting Abstract

    Kosuri, S.; Gyurkocza, B.; Devlin, S.; Maloy, M.; Ciolino, C.; Borrill, T.; Jakubowski, A. A.; Papadopoulos, E. B.; Castro-Malaspina, H. R.; Koehne, G.; more...
    Blood (2015)

    Fulltext@MSK | Save